Vivos Inc (RDGL)
0.1745
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Vivos Enterprise Value: 68.61M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 68.61M |
| May 30, 2024 | 66.61M |
| May 29, 2024 | 64.20M |
| May 28, 2024 | 65.91M |
| May 24, 2024 | 57.58M |
| May 23, 2024 | 57.50M |
| May 22, 2024 | 58.85M |
| May 21, 2024 | 64.76M |
| May 20, 2024 | 66.81M |
| May 17, 2024 | 70.22M |
| May 16, 2024 | 72.46M |
| May 15, 2024 | 78.80M |
| May 14, 2024 | 79.18M |
| May 13, 2024 | 78.00M |
| May 10, 2024 | 78.84M |
| May 09, 2024 | 63.92M |
| May 08, 2024 | 64.16M |
| May 07, 2024 | 68.64M |
| May 06, 2024 | 70.79M |
| May 03, 2024 | 76.52M |
| May 02, 2024 | 82.49M |
| May 01, 2024 | 79.76M |
| April 30, 2024 | 65.90M |
| April 29, 2024 | 59.87M |
| April 26, 2024 | 57.14M |
| Date | Value |
|---|---|
| April 25, 2024 | 45.40M |
| April 24, 2024 | 44.95M |
| April 23, 2024 | 39.59M |
| April 22, 2024 | 40.17M |
| April 19, 2024 | 39.98M |
| April 18, 2024 | 38.84M |
| April 17, 2024 | 39.73M |
| April 16, 2024 | 41.52M |
| April 15, 2024 | 41.30M |
| April 12, 2024 | 39.35M |
| April 11, 2024 | 40.87M |
| April 10, 2024 | 34.51M |
| April 09, 2024 | 31.49M |
| April 08, 2024 | 30.32M |
| April 05, 2024 | 29.83M |
| April 04, 2024 | 28.27M |
| April 03, 2024 | 29.52M |
| April 02, 2024 | 28.04M |
| April 01, 2024 | 27.47M |
| March 31, 2024 | 26.81M |
| March 28, 2024 | 26.58M |
| March 27, 2024 | 26.09M |
| March 26, 2024 | 26.29M |
| March 25, 2024 | 24.97M |
| March 22, 2024 | 24.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.903M
Minimum
Jun 12 2019
82.49M
Maximum
May 02 2024
19.92M
Average
20.31M
Median
Jan 27 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Retractable Technologies Inc | -13.51M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Catheter Precision Inc | 2.370M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5585M |
| Revenue (Quarterly) | 0.0045M |
| Total Expenses (Quarterly) | 0.5816M |
| EPS Diluted (Quarterly) | -0.0014 |
| Gross Profit Margin (Quarterly) | -33.33% |
| Profit Margin (Quarterly) | -12.41K% |
| Earnings Yield | -6.15% |
| Normalized Earnings Yield | -6.151 |